On September 4, 2020 Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, reported its participation in the following upcoming investor conferences (Press release, Fate Therapeutics, SEP 4, 2020, View Source [SID1234564487]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird Global Healthcare Conference on Wednesday, September 9, 2020.
Citi 15th Annual BioPharma Conference on Wednesday, September 9, 2020.
Wells Fargo Healthcare Conference on Thursday, September 10, 2020.
Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 15, 2020.
H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020.
Oppenheimer 30th Annual Healthcare Conference on Tuesday, September 29, 2020.
A live webcast, if recorded, of each presentation will be available through the investor relations section of the Company’s website at www.fatetherapeutics.com. Following each live webcast, an archived replay will be available on the Company’s website.